DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: OCREVUS (ocrelizumab)
       *****************************************************
       #Post#: 2313--------------------------------------------------
       Pretreating Ocrevus patients w/antihistamines and liquids lowers
        infusion reactions by 60%
       By: agate Date: December 21, 2018, 11:52 pm
       ---------------------------------------------------------
       "Pretreating Ocrevus Patients with Multiple Antihistamines and
       Liquids Lowers Infusion Reactions by 60%, Study Reports" from
       Multiple Sclerosis News Today (December 18, 2018):
  HTML https://multiplesclerosisnewstoday.com/2018/12/18/pretreating-ms-patients-with-new-protocol-lowers-infusion-reactions-to-ocrevus-study-reports/?utm_source=Multiple+Sclerosis&utm_campaign=975c5ea29d-RSS_US_EMAIL_CAMPAIGN&utm_medium=email&utm_term=0_b5fb7a3dae-975c5ea29d-71286581
       #Post#: 2334--------------------------------------------------
       New premed protocol improves ocrelizumab treatment for MS
       By: agate Date: January 3, 2019, 11:09 pm
       ---------------------------------------------------------
       More on this from MD Magazine, January 3, 2019--"New Premed
       Protocol Improves Ocrelizumab Treatment for MS":
  HTML https://www.mdmag.com/medical-news/new-premed-protocol-improves-ocrelizumab-treatment-multiple-sclerosis
       *****************************************************